Cary Street Partners Investment Advisory’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-10
Closed -$659 – 1692
2023
Q3
$659 Hold
10
– – ﹤0.01% 1777
2023
Q2
$814 Hold
10
– – ﹤0.01% 1667
2023
Q1
$594 Hold
10
– – ﹤0.01% 1600
2022
Q4
$488 Buy
+10
New +$462 ﹤0.01% 1619

Other funds holding THC

Cary Street Partners Investment Advisory's THC Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Tenet Healthcare (THC) in Q4 2023, closing a stake of 10 shares — an estimated $659 sold.

Cary Street Partners Investment Advisory first reported a position in THC in Q4 2022 and held it in 4 quarters. The position peaked at $814 in Q2 2023. 425 funds tracked by Wall St. Rank hold THC as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Tenet Healthcare position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 10 Tenet Healthcare shares in Q4 2023, an estimated $659.
  • Cary Street Partners Investment Advisory first reported a position in Tenet Healthcare in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Tenet Healthcare position peaked at $814 in Q2 2023.
  • 425 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.